Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.

Antimicrobial agents and chemotherapy - 1 Feb 2001

Patel R, Rouse M S, Piper K E, Steckelberg J M

Abstract excerpt

We compared the activities of linezolid (25 mg/kg of body weight, administered intraperitoneally every 8 h) and of vancomycin (25 mg/kg of body weight, administered intraperitoneally every 8 h) in a rat model of vanA vancomycin-resistant Enterococcus faecium experimental endocarditis. Results were expressed as median log(10) CFU per gram of vegetation after 3 days of treatment. The median log(10) CFU per gram of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetamides
Share to Carbon-Oxygen Ligases
Share to Endocarditis, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Enterococcus faecium

Share to Linezolid

Share to Oxazolidinones

Share to Rats, Wistar

Share to Vancomycin Resistance

Source

Open in PubMed Open full text

Identifiers

PMID: 11158767
DOI: 10.1128/AAC.45.2.621-623.2001
PMCID: PMC90339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.PMID 11158767Read ↗

Linezolid-Resistant, Vancomycin-Resistant Enterococcus faecium Infection in Patients without Prior Exposure to LinezolidSemantic proximity Read ↗

Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.Semantic proximity Read ↗

Clinical-Use-Associated Decrease in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Linezolid: a Comparison with Quinupristin-DalfopristinSemantic proximity Read ↗

Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococciSemantic proximity Read ↗

Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.Semantic proximity Read ↗

Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis.Semantic proximity Read ↗

Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis.Semantic proximity Read ↗

Optimizing Therapy for Vancomycin-Resistant Enterococci (VRE)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.